APA citiranje

Corrêa, T. S., Matos, G. D. R., Segura, M., & dos Anjos, C. H. (2018). Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab. Case Rep Oncol.

Citação norma Chicago

Corrêa, Tatiana Strava, Gustavo Duarte Ramos Matos, Marcos Segura, and Carlos Henrique dos Anjos. "Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) After Progression On Trastuzumab." Case Rep Oncol 2018.

MLA citiranje

Corrêa, Tatiana Strava, Gustavo Duarte Ramos Matos, Marcos Segura, and Carlos Henrique dos Anjos. "Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) After Progression On Trastuzumab." Case Rep Oncol 2018.